doctors in training step 2 2018 page 121

The combination of advances in data science, biotechnology, and digital technology permitting the collection and integration of large amounts of data is essential for the application of AI. 1, 2 In this review, we shall provide a clinician-centric perspective of AI and machine learning (ML) as applied to cardiovascular medicine to highlight the critical requirement of scientific expertise and scrutiny in tandem with technological innovation to avoid negative consequences leading to an AI winter in health care. There is now greater recognition that clinical implementation of AI-based solutions need evidence generation similar to clinical trials. However, both fields have fallen victim to cognitive biases that have led to miscalibration of expectations from early successes. Concurrently, precision medicine has become embedded into medical parlance with notable successes in personalized cancer treatment, giving rise to the expectation that integration of big data and omics along with AI will lead to personalized treatment for all diseases. Over the last decade, artificial intelligence (AI) has transformed all aspects of life (advertising, finance, legal, and medical). At the juncture, there is a critical requirement for clinical and scientific expertise to work in tandem with algorithmic innovation followed by rigorous validation and scrutiny to realize the promise of artificial intelligence-enabled health care for hypertension and other chronic diseases. We focus on the main roadblocks impeding implementation of this technology in clinical care and describe efforts driving potential solutions. In this review, we provide a clinician-centric perspective on artificial intelligence and machine learning as applied to medicine and hypertension. However, artificial intelligence in health care is still in its nascent stages and realizing its potential requires numerous challenges to be overcome.

Artificial intelligence and machine learning, which have made a substantial impact on our everyday lives over the last decade may be the route to this transformation. Hypertension requires transformative solutions that can help reduce the global burden of the disease. Hypertension remains the largest modifiable cause of mortality worldwide despite the availability of effective medications and sustained research efforts over the past 100 years. Customer Service and Ordering Information.Stroke: Vascular and Interventional Neurology.

Journal of the American Heart Association (JAHA).

Circ: Cardiovascular Quality & Outcomes.Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB).

Doctors in training step 2 2018 page 121